IMDX
Insight Molecular Diagnostics Inc. NASDAQ Listed Dec 30, 2015$4.96
Mkt Cap $133.1M
52w Low $2.33
42.6% of range
52w High $8.51
50d MA $4.23
200d MA $4.75
P/E (TTM)
-2.5x
EV/EBITDA
-7.8x
P/B
—
Debt/Equity
-0.1x
ROE
159.6%
P/FCF
-9.0x
RSI (14)
—
ATR (14)
—
Beta
1.53
50d MA
$4.23
200d MA
$4.75
Avg Volume
222.4K
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
15 Cushing · Nashville, TN 92618 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | AMC | -0.24 | -0.27 | -13.7% | 4.11 | +1.5% | -13.4% | -28.4% | +28.6% | +4.9% | +9.3% | — |
| Nov 10, 2025 | AMC | -0.24 | -0.34 | -41.7% | 6.80 | -2.2% | +10.7% | +12.6% | -7.4% | -5.7% | -9.5% | — |
| Aug 11, 2025 | AMC | -0.23 | -0.30 | -30.4% | 2.61 | -6.1% | -3.8% | -2.4% | -2.0% | +0.0% | +11.3% | — |
| May 12, 2025 | AMC | -0.24 | -0.26 | -8.3% | 2.81 | +0.4% | -1.4% | -6.1% | +7.3% | +0.0% | +0.4% | — |
| Mar 24, 2025 | AMC | -0.43 | 0.48 | +211.6% | 3.33 | +9.3% | -8.7% | +4.6% | +1.3% | -0.3% | -4.7% | — |
| Nov 12, 2024 | AMC | -0.44 | -0.98 | -122.7% | 3.00 | +0.0% | -2.0% | -4.8% | -6.8% | +0.8% | -3.0% | — |
| Aug 8, 2024 | AMC | -0.56 | -0.36 | +35.7% | 3.08 | -3.9% | +1.3% | -5.1% | +3.0% | -1.0% | -2.3% | — |
| May 15, 2024 | AMC | -0.67 | -1.13 | -68.7% | 2.95 | -8.5% | +4.1% | -4.6% | -5.8% | +2.2% | +3.2% | — |
| Mar 29, 2024 | AMC | -1.57 | -1.94 | -23.3% | — | — | — | — | — | — | — | — |
| Nov 9, 2023 | AMC | -1.52 | -0.57 | +62.5% | 2.70 | -2.9% | +3.0% | -0.8% | +21.1% | +18.6% | +3.0% | — |
| Aug 10, 2023 | AMC | -2.60 | -1.07 | +58.8% | 3.51 | +0.0% | -0.6% | -2.0% | -2.3% | +0.0% | +0.9% | — |
| May 11, 2023 | AMC | -2.40 | -0.80 | +66.7% | 5.46 | +5.1% | -7.7% | +5.6% | -0.8% | +0.8% | -4.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 | Lake Street | Maintains | Buy → Buy | — | $5.57 | $5.58 | +0.2% | -3.2% | -1.3% | +2.1% | +1.1% | +3.6% |
| Nov 11 | Needham | Maintains | Buy → Buy | — | $6.80 | $6.65 | -2.2% | +10.7% | +12.6% | -7.4% | -5.7% | -9.5% |
| Aug 18 | Needham | Maintains | Buy → Buy | — | $2.40 | $2.51 | +4.6% | +11.2% | -2.6% | -3.8% | -0.8% | +4.4% |
| May 21 | Lake Street | Maintains | Buy → Buy | — | $2.94 | $2.83 | -3.7% | +4.4% | +12.1% | -2.0% | -3.6% | +2.5% |
| May 13 | Needham | Maintains | Buy → Buy | — | $2.81 | $2.82 | +0.4% | -1.4% | -6.1% | +7.3% | +0.0% | +0.4% |
| Apr 8 | Needham | Maintains | Buy → Buy | — | $2.84 | $3.18 | +12.0% | -3.2% | +7.3% | -1.7% | -4.1% | +2.5% |
| Mar 26 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $3.04 | $3.03 | -0.3% | +4.6% | +1.3% | -0.3% | -4.7% | -2.0% |
| Mar 25 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $3.33 | $3.64 | +9.3% | -8.7% | +4.6% | +1.3% | -0.3% | -4.7% |
| Mar 25 | Needham | Maintains | Buy → Buy | — | $3.33 | $3.64 | +9.3% | -8.7% | +4.6% | +1.3% | -0.3% | -4.7% |
| Aug 23 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $3.52 | $3.39 | -3.7% | +4.3% | -7.4% | -2.4% | +3.9% | +2.9% |
| Aug 14 | Piper Sandler | Maintains | Neutral → Neutral | — | $3.49 | $3.37 | -3.4% | -2.0% | -2.3% | +0.0% | +0.9% | +8.6% |
| Aug 9 | Needham | Maintains | Buy → Buy | — | $3.58 | $3.51 | -2.0% | -2.0% | +0.0% | -0.6% | -2.0% | -2.3% |
| Apr 4 | Needham | Maintains | Buy → Buy | — | $6.36 | $6.42 | +0.9% | -8.8% | -6.9% | +14.8% | +12.9% | -3.7% |
| Dec 1 | Lake Street | Downgrade | Buy → Hold | — | $9.40 | $9.40 | +0.0% | +1.1% | +5.1% | -3.8% | +0.0% | -3.3% |
| Nov 18 | Piper Sandler | Downgrade | Overweight → Neutral | — | $8.52 | $8.52 | +0.0% | +3.3% | -3.9% | +6.4% | +5.8% | -1.3% |
| Nov 14 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.40 | $9.60 | +2.1% | -12.8% | -0.5% | -5.1% | +10.1% | +3.3% |
| Nov 11 | Needham | Maintains | Buy → Buy | — | $12.00 | $13.20 | +10.0% | -21.7% | -12.8% | -0.5% | -5.1% | +10.1% |
| Aug 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $18.32 | $18.82 | +2.7% | -4.6% | +5.3% | -1.6% | -1.7% | -1.1% |
| Aug 11 | Lake Street | Maintains | Buy → Buy | — | $19.02 | $19.00 | -0.1% | +2.8% | -3.7% | +3.0% | -5.6% | -4.6% |
| Aug 11 | Needham | Maintains | Buy → Buy | — | $19.02 | $19.00 | -0.1% | +2.8% | -3.7% | +3.0% | -5.6% | -4.6% |
| May 24 | Stephens & Co. | Downgrade | Overweight → Equal Weight | — | $21.60 | $20.60 | -4.6% | -8.9% | -0.4% | +4.1% | +2.0% | +3.8% |
| May 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $22.60 | $22.60 | +0.0% | +2.7% | +0.9% | -2.6% | -1.8% | -0.9% |
| May 12 | Needham | Maintains | Buy → Buy | — | $22.60 | $22.20 | -1.8% | -3.5% | +3.7% | +2.7% | +0.9% | -2.6% |
| Mar 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $26.80 | $27.60 | +3.0% | +19.4% | -11.9% | +0.0% | -2.8% | +1.5% |
| Mar 14 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $25.80 | $25.20 | -2.3% | -10.9% | +0.0% | +4.3% | +11.7% | +19.4% |
| Mar 13 | KeyBanc Capital Markets | Downgrade | Overweight → Equal Weight | — | — | — | — | — | — | — | — | — |
| Mar 11 | Needham | Maintains | Buy → Buy | — | $28.00 | $30.00 | +7.1% | -7.9% | -10.9% | +0.0% | +4.3% | +11.7% |
| Mar 11 | Lake Street | Maintains | Buy → Buy | — | $28.00 | $30.00 | +7.1% | -7.9% | -10.9% | +0.0% | +4.3% | +11.7% |
| Jan 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $41.20 | $41.60 | +1.0% | +0.0% | -1.5% | -3.9% | +0.0% | -4.1% |
| Dec 16 | Needham | Maintains | Buy → Buy | — | $45.80 | $45.80 | +0.0% | -3.9% | -1.8% | +3.7% | +3.1% | +1.3% |
| Nov 10 | Needham | Maintains | Buy → Buy | — | $71.60 | $69.00 | -3.6% | -6.4% | +1.5% | -8.2% | -4.2% | +0.3% |
| Dec 16 | Piper Sandler | Upgrade | Neutral → Overweight | — | $50.60 | $50.40 | -0.4% | +4.0% | -7.2% | +0.8% | +2.8% | +0.8% |
| Nov 30 | BTIG | Maintains | Buy → Buy | — | $35.80 | $38.20 | +6.7% | +7.8% | +0.0% | +1.6% | -0.5% | +1.5% |
| Nov 13 | Needham | Maintains | Buy → Buy | — | $33.60 | $34.00 | +1.2% | +3.6% | +2.9% | +0.0% | -2.2% | +2.3% |
| Nov 10 | KeyBanc | Maintains | Overweight → Overweight | — | $30.40 | $32.80 | +7.9% | +11.8% | +2.9% | -4.0% | +3.6% | +2.9% |
| Jul 30 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $27.40 | $26.20 | -4.4% | +6.6% | -7.5% | +17.8% | +18.9% | -5.8% |
| Jul 29 | Benchmark | Maintains | Speculative Buy → Buy | — | $28.60 | $29.00 | +1.4% | -4.2% | +6.6% | -7.5% | +17.8% | +18.9% |
| Jul 1 | Needham | Maintains | Buy → Buy | — | $38.20 | $35.20 | -7.9% | -12.0% | -7.7% | -14.2% | -6.0% | +2.4% |
| Jun 30 | Chardan Capital | Downgrade | Buy → Neutral | — | $64.60 | $32.00 | -50.5% | -40.9% | -12.0% | -7.7% | -14.2% | -6.0% |
| Jun 2 | Needham | Maintains | Buy → Buy | — | $54.60 | $57.20 | +4.8% | -2.9% | +0.0% | -2.3% | +1.2% | -5.0% |
| Feb 13 | PiperJaffray | Maintains | Overweight → Overweight | — | $76.80 | $83.20 | +8.3% | +0.5% | -0.3% | -1.3% | +0.3% | +0.3% |
| Feb 23 | Chardan Capital | Maintains | Buy → Buy | — | $101.00 | $101.00 | +0.0% | -1.4% | +3.4% | +9.7% | +0.0% | +0.9% |
| May 13 | Benchmark | Maintains | Speculative Buy → Buy | — | $86.60 | $86.00 | -0.7% | -7.2% | -3.5% | +0.8% | +4.1% | +0.7% |
| Mar 24 | Lake Street | Maintains | Buy → Buy | — | $101.20 | $100.00 | -1.2% | +0.2% | +3.7% | -4.0% | -6.3% | -2.5% |
| Mar 15 | Janney Capital | Maintains | Buy → Buy | — | $124.20 | $125.00 | +0.6% | -6.3% | +4.0% | -6.1% | -3.0% | -2.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | — | — | — | 12,684,884 | +9.38% | +25.12% |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | 250,923 | $3.64 | $913K | 12,684,884 | +9.38% | +25.12% |
| Apr 24, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | — | — | — | 12,433,961 | +9.38% | +25.12% |
| Apr 24, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | 38,880 | $3.53 | $137K | 12,433,961 | +9.38% | +25.12% |
| Apr 23, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | — | — | — | 12,395,081 | +9.38% | +25.12% |
| Apr 23, 2026 | BROADWOOD PARTNERS, L.P.10% | — | Buy | 280,381 | $3.50 | $982K | 12,395,081 | +9.38% | +25.12% |
8-K
Unknown — 8-K Filing
IMDX submitted its flagship GraftAssureDx test for FDA review, potentially opening a significant revenue stream in kidney transplant rejection diagnostics if approved.
Mar 26
8-K · 1.01
!! High
Insight Molecular Diagnostics Inc. -- 8-K 1.01: Material Agreement
Insight Molecular Diagnostics partnered with Quest Diagnostics through a specimen collection agreement, potentially expanding IMDX's diagnostic reach and revenue streams via Quest's extensive laboratory network.
Feb 26
8-K · 8.01
!! High
Insight Molecular Diagnostics Inc. -- 8-K 8.01: Material Event / Announcement
IMDX announced a material event that likely signals a significant business development, partnership, or operational change that could substantially impact revenue, profitability, or market position.
Feb 12
8-K · 7.01
! Medium
Insight Molecular Diagnostics Inc. -- 8-K 7.01: Regulation FD Disclosure
Insight Molecular Diagnostics disclosed regulatory information via 8-K filing with no obligation to update materials, indicating a one-time disclosure event rather than ongoing commitment to investors.
Feb 11
Data updated apr 25, 2026 3:16pm
· Source: massive.com